BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paquin-Proulx D, Santos BA, Carvalho KI, Toledo-Barros M, Barreto de Oliveira AK, Kokron CM, Kalil J, Moll M, Kallas EG, Sandberg JK. IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. PLoS One 2013;8:e75199. [PMID: 24130688 DOI: 10.1371/journal.pone.0075199] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Abolhassani H, Asgardoon MH, Rezaei N, Hammarstrom L, Aghamohammadi A. Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient? Expert Review of Clinical Immunology 2015;11:1229-43. [DOI: 10.1586/1744666x.2015.1079485] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
2 Cavaliere FM, Prezzo A, Conti V, Bilotta C, Pulvirenti F, Iacobini M, Quinti I. Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies. International Immunopharmacology 2015;28:596-603. [DOI: 10.1016/j.intimp.2015.07.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Kurmann R, Weisstanner C, Kardas P, Hirsch HH, Wiest R, Lämmle B, Furrer H, Du Pasquier R, Bassetti CL, Sturzenegger M, Krestel H. Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. J Neurovirol 2015;21:694-701. [PMID: 25916731 DOI: 10.1007/s13365-015-0340-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
4 Duraisingham SS, Manson A, Grigoriadou S, Buckland M, Tong CY, Longhurst HJ. Immune deficiency: changing spectrum of pathogens. Clin Exp Immunol 2015;181:267-74. [PMID: 25677249 DOI: 10.1111/cei.12600] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
5 Maddur MS, Kaveri SV, Bayry J. Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin. Trends Immunol 2017;38:789-92. [PMID: 28916232 DOI: 10.1016/j.it.2017.08.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
6 de Lollo C, de Moraes Vasconcelos D, da Silva Oliveira LM, de Oliveira Titz T, Carneiro-Sampaio M, Jacob CM, da Silva Duarte AJ, Sato MN. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency. J Transl Med 2016;14:138. [PMID: 27188997 DOI: 10.1186/s12967-016-0900-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
7 Malone DF, Falconer K, Weiland O, Sandberg JK. The dynamic relationship between innate immune biomarkers and interferon-based treatment effects and outcome in hepatitis C virus infection is altered by telaprevir. PLoS One 2014;9:e105665. [PMID: 25166593 DOI: 10.1371/journal.pone.0105665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
8 Dinh T, Oh J, Cameron DW, Lee SH, Cowan J. Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency. PLoS One 2019;14:e0223861. [PMID: 31613907 DOI: 10.1371/journal.pone.0223861] [Reference Citation Analysis]
9 Berbers R, Nierkens S, van Laar JM, Bogaert D, Leavis HL. Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences. Trends in Immunology 2017;38:206-16. [DOI: 10.1016/j.it.2016.11.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
10 Azizi G, Hafezi N, Mohammadi H, Yazdani R, Alinia T, Tavakol M, Aghamohammadi A, Mirshafiey A. Abnormality of regulatory T cells in common variable immunodeficiency. Cellular Immunology 2017;315:11-7. [DOI: 10.1016/j.cellimm.2016.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
11 Sadati ZA, Motedayyen H, Sherkat R, Ostadi V, Eskandari N. Comparison of the Percentage of Regulatory T cells and their p-STAT5 Expression in Allergic and Non-Allergic Common Variable Immunodeficiency Patients. Immunological Investigations 2019;48:52-63. [DOI: 10.1080/08820139.2018.1498882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
12 Zdziarski P, Gamian A. Lymphoid Interstitial Pneumonia in Common Variable Immune Deficiency - Case Report With Disease Monitoring in Various Therapeutic Options: Pleiotropic Effects of Rituximab Regimens. Front Pharmacol 2018;9:1559. [PMID: 30713498 DOI: 10.3389/fphar.2018.01559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
13 Mitrevski M, Marrapodi R, Camponeschi A, Lazzeri C, Todi L, Quinti I, Fiorilli M, Visentini M. Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells. Immunol Res 2014;60:330-8. [PMID: 25407649 DOI: 10.1007/s12026-014-8599-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
14 Ciccocioppo R, Comoli P, Gallia A, Basso S, Baldanti F, Corazza GR. Autologous human cytomegalovirus-specific cytotoxic T cells as rescue therapy for ulcerative enteritis in primary immunodeficiency. J Clin Immunol 2014;34:681-5. [PMID: 24888600 DOI: 10.1007/s10875-014-0060-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, Roger T, Lacabaratz C, Bart PA, Levy Y, Pantaleo G. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med 2014;211:2033-45. [PMID: 25225461 DOI: 10.1084/jem.20140039] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
16 Cowan J, Gaudet L, Mulpuru S, Corrales-Medina V, Hawken S, Cameron C, Aaron SD, Cameron DW. A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PLoS One 2015;10:e0142205. [PMID: 26558756 DOI: 10.1371/journal.pone.0142205] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
17 Paquin-Proulx D, Sandberg JK. Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression. Front Immunol 2014;5:637. [PMID: 25566250 DOI: 10.3389/fimmu.2014.00637] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
18 Erazo-Borrás LV, Álvarez-Álvarez JA, Perez-Romero CA, Orrego-Arango JC, Franco-Restrepo JL, Trujillo-Vargas CM. Skewed Invariant Natural Killer T (iNKT) Cells, Impaired iNKT:B Cell Help and Decreased SAP Expression in Blood Lymphocytes from Patients with Common Variable Immunodeficiency. Scand J Immunol 2017;86:171-8. [PMID: 29083052 DOI: 10.1111/sji.12576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Lollo C, de Moraes Vasconcelos D, Oliveira LMDS, Domingues R, Carvalho GC, Duarte AJDS, Sato MN. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency. Clin Immunol 2016;169:121-7. [PMID: 27392462 DOI: 10.1016/j.clim.2016.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Gao Y, Gadola S, Grimbacher B, Williams AP. Reply: To PMID 24582167. J Allergy Clin Immunol 2014;134:990. [PMID: 25159467 DOI: 10.1016/j.jaci.2014.06.040] [Reference Citation Analysis]
21 Paquin-Proulx D, Santos BA, Carvalho KI, Toledo-Barros M, Oliveira AK, Kokron CM, Kalil J, Moll M, Kallas EG, Sandberg JK. Invariant natural killer T cells in patients with common variable immunodeficiency. J Allergy Clin Immunol 2014;134:989-90. [PMID: 25159463 DOI: 10.1016/j.jaci.2014.06.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Tanir Basaranoglu S, Cekic S, Kirhan E, Dirican M, Kilic SS. Oxidative stress in common variable immunodeficiency. Eur J Inflamm 2021;19:205873922110024. [DOI: 10.1177/20587392211002411] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tjon AS, van Gent R, Geijtenbeek TB, Kwekkeboom J. Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye. Front Immunol 2015;6:197. [PMID: 25972869 DOI: 10.3389/fimmu.2015.00197] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
24 David Morgan M, Richter A, Al‐ali S, Flint J, Yiannakis C, Drayson M, Goldblatt D, Harper L. Association of Low B Cell Count and IgG Levels With Infection, and Poor Vaccine Response With All‐Cause Mortality in an Immunosuppressed Vasculitis Population. Arthritis Care & Research 2016;68:853-60. [DOI: 10.1002/acr.22757] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
25 Abbott JK, Gelfand EW. Common Variable Immunodeficiency: Diagnosis, Management, and Treatment. Immunol Allergy Clin North Am 2015;35:637-58. [PMID: 26454311 DOI: 10.1016/j.iac.2015.07.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
26 Rosca EC, Rosca O, Simu M. Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barré syndrome. Int Immunopharmacol 2015;29:964-5. [PMID: 26428850 DOI: 10.1016/j.intimp.2015.09.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Paquin-Proulx D, Barsotti NS, Santos BAN, Marinho AKBB, Kokron CM, Carvalho KI, Barros MT, Kalil J, Nixon DF, Kallas EG. Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion. Medicine (Baltimore) 2016;95:e4304. [PMID: 27472706 DOI: 10.1097/MD.0000000000004304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
28 Parasa VR, Selvaraj A, Sikhamani R, Raja A. Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro. Clin Exp Med 2015;15:205-13. [PMID: 24748538 DOI: 10.1007/s10238-014-0278-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
29 Shin JJ, Catanzaro J, Yonkof JR, Delmonte O, Sacco K, Shin MS, Reddy S, Whittington PJ, Soffer G, Mustillo PJ, Sullivan KE, Notarangelo LD, Abraham RS, Romberg N, Kang I. Infectious Complications Predict Premature CD8+ T-cell Senescence in CD40 Ligand-Deficient Patients. J Clin Immunol 2021;41:795-806. [PMID: 33495902 DOI: 10.1007/s10875-021-00968-x] [Reference Citation Analysis]
30 Dolcino M, Patuzzo G, Barbieri A, Tinazzi E, Rizzi M, Beri R, Argentino G, Ottria A, Lunardi C, Puccetti A. Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapy. PLoS One 2014;9:e97571. [PMID: 24831519 DOI: 10.1371/journal.pone.0097571] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
31 Quinti I, Mitrevski M. Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells. Front Immunol 2017;8:697. [PMID: 28670314 DOI: 10.3389/fimmu.2017.00697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Klarquist J, Cross EW, Thompson SB, Willett B, Aldridge DL, Caffrey-Carr AK, Xu Z, Hunter CA, Getahun A, Kedl RM. B cells promote CD8 T cell primary and memory responses to subunit vaccines. Cell Rep 2021;36:109591. [PMID: 34433030 DOI: 10.1016/j.celrep.2021.109591] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Matucci A, Maggi E, Vultaggio A. Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects. Front Immunol 2014;5:690. [PMID: 25628625 DOI: 10.3389/fimmu.2014.00690] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
34 Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, Rezaei N, Ochs HD, Aghamohammadi A. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Review of Clinical Immunology 2016;13:101-15. [DOI: 10.1080/1744666x.2016.1224664] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
35 Pellicciotta M, Rigoni R, Falcone EL, Holland SM, Villa A, Cassani B. The microbiome and immunodeficiencies: Lessons from rare diseases. J Autoimmun. 2019;98:132-148. [PMID: 30704941 DOI: 10.1016/j.jaut.2019.01.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]